Laserfiche WebLink
CHEVRON EMC 9 58420213 03/29 '00 14:31 NO.689 03/06 <br /> ' • • 4003/U06 <br /> Wendy Wyels <br /> ' August 13, 1997 <br /> Page 2 <br /> R_U document are required, please reference this written memorandum as documenting the <br /> ' approval byDTSC of both the risk evaluation <br /> a <br /> stochastic analysis. work plan and the input distributions for the <br /> Since a stochastic assessment is an estimate based upon random sampling from,the input <br /> spreadshouts, individual "runs" n 5,000 to 10,000 trials, we commonly require the electronic <br /> spreadsheets developed for the analysis, so that we may independently verify the run results, the <br /> ' shape of the frequency distributions, and the sensitivity analyses. ?hese cleckonic spreadsheets <br /> run results constituted the bulk of our <br /> have been supplied by Geomatrix, and our analysis of the <br /> review. <br /> Finally, a supplemental risk evaluation was rrcommcnded by DTSC to evaluate public exposures to <br /> unconventional media,of exposure, i.e., neither soil, air or water, These include that oily material <br /> ' which exists underground at Alden park to which only occasional contact is expected. Standard <br /> risk assessment Parameters, such as daily ingestion rates, doroti exist for such materia] so this <br /> Cons with our experience with buried wastes, the impact of <br /> requires separate evaluation. Con <br /> ' short-term exposures to relatively high concentrations of this material was evaluated. <br /> GENERAL COMMENTS <br /> Potency Equival.encv Factors for Carcinogenic Polycyclic Aromatic Hydrocarbons (Section <br /> 4.0,page 11; also Table 4) <br /> Please be advised that the potency equivalency factnr(PEF) for dibenzo h an <br /> OA is applicable only to the oral route of exposure. 1t is based upon a comparisons o theof <br /> ' known oral potency of benzo(a)pyrenc (12 mg/kg-day-1)to that of dibenzo <br /> (4.1 mg/kg-da (a h)anthracen,ene is e <br /> inhalation Potency of. dibenzo(a h)antbracene is irectly eof rxtrapolated gtheaoral potency, <br /> ' Therefore, the inhalation PEF of dibenzo(a h)anthracenc should be J. <br /> While this represents a technical error in the document it does not contribute significantly to <br /> the overall risk . The detection frequency for this individual chemical was quite low, and <br /> it's proportional contribution via the inhalation pathway to the additive risk of all <br /> alone, <br /> polycyclic aromatic hydrocarbons do not warrant revision of the document for this reason <br /> ' <br /> 2, Stochastic Risk Analysis to Produce Refined Screening Levels <br /> The electronic spreadsheet used to generate the "Refined Screening Levels" was reviewed, <br /> rather than the main text of the document itself This fle is representative of the earlier <br /> ' agreements reached with technical staff, and all elements of the report'under review <br /> essentially reproduced. We recommewere that a wntp-protected and password-protected <br /> version of this spreadsheet be submitted to your Board and accornpany the document in the <br />